CRNX
Price
$35.60
Change
-$3.38 (-8.67%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
3.3B
63 days until earnings call
IGMS
Price
$1.74
Change
-$0.03 (-1.69%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
101.68M
72 days until earnings call
Ad is loading...

CRNX vs IGMS

Header iconCRNX vs IGMS Comparison
Open Charts CRNX vs IGMSBanner chart's image
Crinetics Pharmaceuticals
Price$35.60
Change-$3.38 (-8.67%)
Volume$80.07K
Capitalization3.3B
IGM Biosciences
Price$1.74
Change-$0.03 (-1.69%)
Volume$16.97K
Capitalization101.68M
CRNX vs IGMS Comparison Chart
Loading...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IGMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRNX vs. IGMS commentary
Jan 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRNX is a Hold and IGMS is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 15, 2025
Stock price -- (CRNX: $35.62 vs. IGMS: $1.71)
Brand notoriety: CRNX and IGMS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRNX: 238% vs. IGMS: 208%
Market capitalization -- CRNX: $3.3B vs. IGMS: $101.68M
CRNX [@Biotechnology] is valued at $3.3B. IGMS’s [@Biotechnology] market capitalization is $101.68M. The market cap for tickers in the [@Biotechnology] industry ranges from $374.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.41B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRNX’s FA Score shows that 0 FA rating(s) are green whileIGMS’s FA Score has 0 green FA rating(s).

  • CRNX’s FA Score: 0 green, 5 red.
  • IGMS’s FA Score: 0 green, 5 red.
According to our system of comparison, CRNX is a better buy in the long-term than IGMS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRNX’s TA Score shows that 3 TA indicator(s) are bullish while IGMS’s TA Score has 4 bullish TA indicator(s).

  • CRNX’s TA Score: 3 bullish, 4 bearish.
  • IGMS’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, IGMS is a better buy in the short-term than CRNX.

Price Growth

CRNX (@Biotechnology) experienced а -27.92% price change this week, while IGMS (@Biotechnology) price change was -74.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.85%. For the same industry, the average monthly price growth was -2.06%, and the average quarterly price growth was -3.70%.

Reported Earning Dates

CRNX is expected to report earnings on May 08, 2025.

IGMS is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-6.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($3.3B) has a higher market cap than IGMS($102M). CRNX YTD gains are higher at: -23.763 vs. IGMS (-70.949). IGMS has higher annual earnings (EBITDA): -225.78M vs. CRNX (-304.51M). CRNX has more cash in the bank: 863M vs. IGMS (219M). IGMS has less debt than CRNX: IGMS (45.9M) vs CRNX (52.5M). IGMS has higher revenues than CRNX: IGMS (2.92M) vs CRNX (1.04M).
CRNXIGMSCRNX / IGMS
Capitalization3.3B102M3,238%
EBITDA-304.51M-225.78M135%
Gain YTD-23.763-70.94933%
P/E RatioN/AN/A-
Revenue1.04M2.92M36%
Total Cash863M219M394%
Total Debt52.5M45.9M114%
FUNDAMENTALS RATINGS
CRNX: Fundamental Ratings
CRNX
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
PROFIT vs RISK RATING
1..100
38
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRNXIGMS
RSI
ODDS (%)
N/A
Bullish Trend 7 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 7 days ago
82%
Bullish Trend 7 days ago
81%
Momentum
ODDS (%)
Bearish Trend 7 days ago
79%
N/A
MACD
ODDS (%)
N/A
Bullish Trend 7 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 7 days ago
78%
Bullish Trend 7 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
76%
Bearish Trend 7 days ago
89%
Advances
ODDS (%)
Bullish Trend 12 days ago
81%
Bullish Trend 12 days ago
82%
Declines
ODDS (%)
Bearish Trend 7 days ago
80%
Bearish Trend 16 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 7 days ago
80%
Bearish Trend 7 days ago
88%
View a ticker or compare two or three
Ad is loading...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IGMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IENRX9.300.06
+0.65%
Macquarie Climate Solutions R6
BQLCX21.980.11
+0.50%
Bright Rock Quality Large Cap Instl
FHCCX39.870.14
+0.35%
Fidelity Advisor Health Care C
CLBFX34.080.01
+0.03%
American Funds American Balanced 529F
EVSAX22.98N/A
N/A
Allspring Disciplined US Core A

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with MRSN. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then MRSN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
-3.97%
MRSN - CRNX
51%
Loosely correlated
-13.68%
XENE - CRNX
47%
Loosely correlated
-0.42%
TRDA - CRNX
46%
Loosely correlated
-8.74%
DYN - CRNX
46%
Loosely correlated
-3.65%
ARWR - CRNX
46%
Loosely correlated
+2.27%
More

IGMS and

Correlation & Price change

A.I.dvisor indicates that over the last year, IGMS has been loosely correlated with INZY. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IGMS jumps, then INZY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IGMS
1D Price
Change %
IGMS100%
-15.07%
INZY - IGMS
54%
Loosely correlated
-13.78%
MRSN - IGMS
53%
Loosely correlated
-13.68%
NTLA - IGMS
44%
Loosely correlated
-1.47%
CRNX - IGMS
43%
Loosely correlated
-3.97%
MDGL - IGMS
42%
Loosely correlated
-10.39%
More